What Happened

A pharmacist in Gate City, Virginia, was sentenced to 24 months in federal prison after pleading guilty to tampering with oxycodone and hydromorphone at the pharmacy where he worked.

He swapped oxycodone tablets with prednisone, a steroid used to treat inflammation, and swapped hydromorphone tablets with leflunomide, a drug used to treat rheumatoid arthritis, then dispensed the substituted pills to unsuspecting patients. Separately, he would shorten some patients' prescriptions — dispensing fewer pills than prescribed — and keep the withheld controlled-substance tablets for himself.

Investigators noted that because he tampered with the products themselves rather than simply stealing whole bottles, a pharmacist filling a later prescription from the same stock could unknowingly dispense the wrong medication to a different customer, putting patients who trusted the pharmacy at risk of receiving an ineffective or inappropriate drug. He pleaded guilty in June 2024 to one count of tampering with consumer products.

What Went Wrong

  • Pill counts at the pharmacy did not catch a pattern of shorted prescriptions over time.
  • Tablets swapped for look-alike non-controlled medications were not detected before reaching patients or being returned to pharmacy stock.
  • No independent verification confirmed that dispensed tablets matched their labeled identity before reaching the patient.

How It Could Have Been Prevented

  • Perform regular, unannounced pill counts and reconciliation against dispensing records for high-diversion-risk controlled substances.
  • Require a second pharmacist or technician to independently verify pill identity and count before a controlled-substance prescription is finalized.
  • Train staff and patients to recognize and report unexpected changes in a medication's appearance.
  • Monitor for patterns of shorted or partial fills across a pharmacist's dispensing history.

Related Guidance

Sources